Promis Neurosciences (PMN)
(Delayed Data from NSDQ)
$1.09 USD
-0.02 (-1.80%)
Updated Oct 4, 2024 03:58 PM ET
After-Market: $1.09 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
PMN 1.09 -0.02(-1.80%)
Will PMN be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for PMN based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for PMN
Video: Wednesday 9/25 Insider Buying Report: PMN, BHVN
Director Madge Shafmaster Acquires 200,000 Shares of ProMIS Neurosciences Inc (PMN)
ProMIS Neurosciences to Showcase PMN310?s Ability to Target Toxic Oligomers and Distinguish from Other Amyloid-Beta Oligomers in Preclinical Studies at the 4th International Conference on Cognitive & Behavioral Neurosciences
ProMIS Neurosciences to showcase PMN310 at ICBN
ProMIS Neurosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference